MBZUAI and GenBio AI have won the UAE AI Award 2025 in the AI Scientific Research category for their "Unified Protein Language Modeling Framework". The winning project enables AI to learn protein function, generate sequences, and predict 3D structures. The AI-driven simulation approach aims to accelerate drug development, reduce costs, and improve success rates. Why it matters: This award highlights the UAE's commitment to fostering AI innovation in biomedicine and drug discovery, positioning the region as a leader in AI-driven healthcare advancements.
MBZUAI and BioMap have signed an MoU to establish the first biocomputing innovation research lab in the Middle East, located on MBZUAI's campus. The collaboration will focus on applying AI protein generation to life science models, addressing needs in drug design, energy, and environmental protection. The lab will research de novo design of oil degradation enzymes and identify drug targets for aging-associated and rare diseases. Why it matters: This partnership signals a growing focus on applying AI to critical life science challenges in the region, potentially leading to breakthroughs in drug discovery and sustainable energy solutions.
MBZUAI has announced partnerships with IBT and BioMap to advance AI applications in healthcare. The collaboration with IBT will focus on developing personalized digital therapeutics for brain health. The partnership with BioMap will establish a biocomputing innovation research lab in the Middle East focused on AI-generated proteins. Why it matters: These partnerships highlight MBZUAI's commitment to leveraging AI for personalized healthcare solutions and establishing the UAE as a hub for biocomputing innovation.
MBZUAI's BiMediX2, a bilingual healthcare multi-modal model, won Meta's Llama Impact Innovation Award for its potential in solving healthcare accessibility challenges across the Middle East and Africa. Built using Llama 3.1, the model understands medical queries in both English and Arabic, interprets medical images, and is integrated as a chatbot on Telegram with speech functionality. The model was also presented at the AI for Sustainable Development Platform Launch Event and integrated into the UNDP for telemedicine. Why it matters: The model's bilingual capabilities and accessibility on low-cost devices and speech-based interaction have potential to improve healthcare access for marginalized populations in the region.
MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.